Can a nerve pacemaker tame Post-Cancer bowel chaos?
NCT ID NCT07761884
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This trial tests whether implanting a sacral neuromodulation device soon after rectal cancer surgery can reduce severe bowel urgency and incontinence, known as low anterior resection syndrome (LARS). Half of the participants receive the device within 120 days of surgery, while the other half gets standard conservative care. The goal is to see if early nerve stimulation improves bowel control and daily life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sacral neuromodulation, a device that sends mild electrical pulses to the sacral nerves to help control bowel function
- What this could lead to
- If effective, early sacral neuromodulation could offer a new way to reduce severe bowel urgency and incontinence after rectal cancer surgery, improving quality of life.
- What could go wrong
- This is a small pilot study, so results may not apply broadly. The device requires surgery and carries risks like infection or lead migration, and not all patients may respond.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW ANTERIOR RESECTION SYNDROME (LARS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vall d'Hebron Barcelona Hospital Campus
Barcelona, Catalonia, 08035, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.